Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of AF37702 Injection for Maintenance Treatment of Anaemia in Chronic Kidney Disease
2008-003458-13Phase 2Completed
- Sponsor
- Takeda
- Start
- Jul 2008
- Modality
- Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of peginesatide in anaemia and Uraemic Anaemia, sponsored by Takeda. Started Jul 2008; status: completed.
02
Drugs
peginesatide
03
Conditions
anaemiaUraemic Anaemia
Beyond the preview
Go deeper on 2008-003458-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003458-13.